BCYC Q1 2020 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-82.3% YoY

Gross Profit

-$7M-588.6% margin

Operating Income

-$12M-1031.3% margin

Net Income

-$11M-1003.0% margin

EPS (Diluted)

$-0.63

QoQ Revenue Growth

-78.6%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$21M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$129M

Total Liabilities

$47M

Stockholders' Equity

$82M

Cash & Equivalents

$110M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$6M	-82.3%
Gross Profit	-$7M	$108,000	-6252.8%
Operating Income	-$12M	-$3M	-253.5%
Net Income	-$11M	-$7M	-74.1%